Gå direkt till huvudinnehållet

Kikhosta

Senast uppdaterad: Senast reviderad:
Sakkunnig:
Definition:
Infektion med bakterien Bordetella pertussis som leder till hosta som håller i sig i upp till sex veckor med hostanfall och kraftiga inandningar (kikningar).
Förekomst:
Ökande förekomst i alla åldersgrupper, störst ökning bland tonåringar och vuxna. 603 rapporterade fall i Sverige 2015.
Symtom:
Den kliniska bilden kan variera mycket och beror på patientens ålder. Klassiska kikningar saknas ofta, särskilt efter barnaåren.
Kliniska fynd:
Kliniska fynd är beskedliga, ev. lätt rodnad i slemhinnor i övre luftvägar.
Diagnostik:
PCR är en känslig metod som ger snabbt svar, men bör tas inom tre-till fyra veckor efter symtomdebut.
Behandling:
Antibiotika har effekt om det ges inom tre veckor efter symtomdebut (bäst effekt i det katarrala stadiet).
  1. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367: 1926-36. PubMed  
  2. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28: 1230-7. PubMed  
  3. Halperin SA. Pertussis - a disease and vaccine for all ages. N Engl J Med 2005; 353: 1615-7. PubMed  
  4. Bordet J, Gengou U. Le microbe de la coqueluche. Ann Inst Pasteur 1906; 20: 48-68. PubMed  
  5. Folkhälsomyndigheten: Kikhosta, statistik www.folkhalsomyndigheten.se  
  6. World Health Organization. Expanded programme on immunization. Global Advisory Group Meeting, 14 - 18 October, Antalya, Turkey. Report No. 49. Genève: WHO, 1992.
  7. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185: 1448-53. PubMed  
  8. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-82. PubMed  
  9. Gregory DS. Pertussis: A disease affecting all ages. Am Fam Physician 2006; 74: 420-6. PubMed  
  10. Halperin SA, Smith B, Russell M, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000; 18: 1312-9. PubMed  
  11. Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63. New England Journal of Medicine  
  12. Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M. Kikhoste - et økende problem i Norge. Tidsskr Nor Lægeforen 2006; 126: 305-8. PubMed  
  13. Faye-Lund A, Syversen G, Wathne K-O. Kikhoste hos barn. Tidsskr Nor Lægeforen 2007; 127: 1938-40. PubMed  
  14. Pontoppidan PE, Høgh B. Antibiotikabehandling af kighoste. Ugeskr Læger 2006; 168: 2802-5. PubMed  
  15. Moore A, Ashdown HF, Shinkins B, et al. Clinical Characteristics of Pertussis-Associated Cough in Adults and Children: A Diagnostic Systematic Review and Meta-Analysis. Chest 2017; 152: 353-67. pmid:28511929 PubMed  
  16. Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005; 24: S19-S24. pmid:15876919 PubMed  
  17. Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? Clin Infect Dis 2001; 15: 1698-9. PubMed  
  18. Heininger U, Cherry JD, Eckhardt T et al. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr Infect Dis J 1993; 12: 504-9. PubMed  
  19. Schlapfer G, Cherry JD, Heininger U et al. Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J 1995; 14: 209-14. PubMed  
  20. Heininger U, Stehr K, Cherry JD. Serious pertussis overlooked in infants. Eur J Pediatr 1992; 151: 342-3. PubMed  
  21. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-9. PubMed  
  22. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183: 1353-9. PubMed  
  23. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35: 2435-43. PubMed  
  24. Cherry JD, Grimprel E, Guiso N et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005; 24: S25-S34. pmid:15876920 PubMed  
  25. Fung KSC, Yeung WL, Wong TW, So KW, Cheng AFB. Pertussis - a re-emerging infection? J Infect 2004; 48: 145 - 8. PubMed  
  26. Tinnion ON. Acellular vaccines for preventing whooping cough in children. Cochrane Library, Issue 1, 1999. The Cochrane Library  
  27. Edwards KM. Overview of pertussis. Focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005; 24: 104-7. PubMed  
  28. Rekommendation om vaccination mot kikhosta för gravida. Folkhälsomyndigheten, hämtad 2022-09-05. www.folkhalsomyndigheten.se  
  29. Ward JI, Cherry JD, Chang SJ et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63. New England Journal of Medicine  
  30. Postels-Multani S, Schmitt HJ, Wirsing von Konig CH et al. Symptoms and complications of pertussis in adults. Infection 1995; 23: 139-42. PubMed  
  31. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 24: S44-S47. pmid:15876923 PubMed  
  32. Wendelboe AM, Van RA, Salmaso S et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24: S58 - S61. pmid:15876927 PubMed  
  • Bengt Granström, överläkare, barn-och ungdomsmedicinska kliniken, Skånes universitetssjukhus

Tidigare sakkunniga

  • Ellen Berit Nordal, överläkare, barneavdelingen, Regionsykehuset i Tromsø
  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim
  • Dag Berild, överläkare, medisinsk klinikk, Aker Sykehus